⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20210863 | 0.77 | — | — | |
| SCHEMBL8196768 | 0.74 | LMNA (0.37) | — | |
| SCHEMBL8089187 | 0.74 | LMNA (0.39) | — | |
| SCHEMBL11736717 | 0.72 | — | — | |
| SCHEMBL14968279 | 0.70 | — | — | |
| SCHEMBL3679400 | 0.70 | TSHR (0.46) | — | |
| SCHEMBL562402 | 0.70 | — | — | |
| SCHEMBL7872310 | 0.69 | — | — | |
| SCHEMBL561673 | 0.67 | — | — | |
| SCHEMBL12306473 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320233-A1 | ARGINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAEWOONG PHARMACEUTICAL CO LTD (KR) | 2025-10-16 | — | — | US | disclosed |
| EP-4538278-A1 | ARGINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Daewoong Pharmaceutical Co., Ltd. (KR) | 2025-04-16 | — | — | EP | disclosed |
| EP-0399284-A2 | Method for the production of geminal diarylalkanes, geminal diarylalkanes and alk(en)ylated aromatic compounds | BAYER AG (DE) | 1990-11-28 | — | — | EP | disclosed |